LOADING
Thyroid conditions affect millions of Americans, and veterans face unique risks from radiation exposure, chemical exposure, and the stress-related autoimmune conditions that can develop after traumatic service experiences. The VA rates thyroid conditions under 38 CFR 4.119, with distinct criteria for hyperthyroidism, hypothyroidism, and thyroid cancer. A significant regulatory change in 2021 substantially altered the hypothyroidism rating framework, which veterans should understand.
Hyperthyroidism is rated under Diagnostic Code 7900. A 10 percent rating applies for tachycardia that can be controlled with medication. A 30 percent rating applies for tachycardia, tremor, and increased pulse pressure or blood pressure. A 60 percent rating applies for emotional instability, fatigability, and increased pulse pressure, or blood pressure, or tachycardia. A 100 percent rating applies for thyroid enlargement, tachycardia greater than 100 beats per minute, eye involvement, muscular weakness, loss of weight, and sympathetic nervous system, cardiovascular, or gastrointestinal symptoms.
Hypothyroidism was historically rated under DC 7903 using a similar symptom-based framework. In 2021, the VA revised the rating criteria for endocrine conditions including hypothyroidism. Under the current DC 7903, hypothyroidism is rated at zero percent if symptoms are controlled with continuous medication, 30 percent for signs or symptoms due to hypothyroidism sufficient to require continuous medication for control, 60 percent for generalized non-cardiovascular symptoms including symptoms of mental or emotional nature, and 100 percent for myxedema or crisis requiring hospitalization or with cardiovascular, gastrointestinal, or respiratory symptoms.
The 2021 rule change was controversial because it reduced the baseline rating for treated hypothyroidism from 30 percent to zero percent for many veterans. The VA's reasoning was that modern thyroid replacement therapy with levothyroxine effectively normalizes thyroid function in most patients, so a compensable rating is not warranted for well-controlled disease. Veterans whose hypothyroidism continues to produce symptoms despite treatment can still qualify for higher ratings based on residual symptoms, but the baseline has shifted significantly.
Veterans with existing ratings for hypothyroidism under the pre-2021 rules are protected under 38 CFR 3.951. A rating in effect for five or more years is stabilized and cannot be reduced without clear evidence of sustained material improvement. Veterans with pre-existing 30 percent ratings for hypothyroidism should not see reductions merely because the rating criteria changed.
Thyroid cancer is rated under DC 7914 and receives 100 percent during active treatment. Six months after cessation of therapy, the rating is re-evaluated. Residuals are rated based on any residual thyroid dysfunction, typically hypothyroidism from surgical removal of the thyroid, plus any other treatment residuals. Veterans who have had thyroidectomy for cancer typically transition to a hypothyroidism rating based on the post-surgical treatment status.
Service connection for thyroid conditions can be established through several pathways. Radiation exposure is a recognized cause of thyroid cancer and other thyroid conditions. Veterans who participated in atmospheric nuclear testing, served in specific locations during atomic weapons operations, or were exposed to radiation during occupation of Hiroshima or Nagasaki qualify for presumptive service connection for thyroid cancer. Agent Orange exposure has been linked to thyroid dysfunction through endocrine disruption mechanisms, and some thyroid conditions have been pursued on a direct or secondary basis for Vietnam-era veterans.
Autoimmune thyroid conditions like Hashimoto thyroiditis and Graves disease are increasingly pursued as service-connected conditions. The autoimmune pathogenesis is complex, but there is growing recognition that chronic stress including combat stress, exposure to environmental toxins, and infections during service can trigger autoimmune responses that culminate in thyroid dysfunction. A well-supported nexus letter can establish service connection for these conditions.
Evidence for a thyroid claim includes thyroid function laboratory values over time including TSH, free T4, and thyroid antibodies, endocrinology consultation notes, imaging such as thyroid ultrasound, any surgical or biopsy reports, radiation exposure documentation for presumptive claims, and a list of current thyroid medications. For autoimmune claims, a nexus letter connecting service events to the development of the autoimmune condition strengthens the claim.
The C&P exam for thyroid conditions includes a focused history, physical examination assessing thyroid gland size, heart rate, and signs of hyper or hypothyroidism, review of laboratory data, and completion of the endocrine conditions DBQ. Describe all symptoms including fatigue, weight changes, temperature intolerance, mood changes, constipation or diarrhea, hair and skin changes, and cardiovascular symptoms.
Secondary conditions from thyroid dysfunction include cardiovascular conditions from prolonged untreated hyperthyroidism, cognitive and mood disorders from hypothyroidism, and infertility. Graves ophthalmopathy can cause eye complications that may be separately ratable. Each secondary condition can be pursued with appropriate medical support.
The ClaimRecon Rating Calculator helps you see how thyroid condition ratings combine with your other service-connected conditions, including the common secondary conditions that develop with thyroid dysfunction. The C&P Exam Simulator walks through the endocrine DBQ questions for thyroid conditions. The Secondary Condition Finder maps thyroid dysfunction to related conditions including cardiovascular effects, mood disorders, and female reproductive issues. The Personal Statement Builder helps you articulate the broad range of symptoms thyroid disease produces.
Disclaimer: This article is for educational and informational purposes only. It does not constitute legal, medical, or VA claims advice. Endocrine rating criteria under 38 CFR 4.119 are subject to change. Always verify current criteria at VA.gov or consult with an accredited VSO, attorney, or claims agent before making decisions about your benefits.
Written by ClaimRecon Editorial